On 28th September 2010 OBN will be showcasing the latest life science spin-outs and start-ups at its first London BioTuesday, where it hopes to raise the profile of these exciting companies with a mixed audience of investors, R&D companies and other members.
From stem cell technology, new monoclonal antibody therapeutics and services, pre-clinical respiratory drug discovery, novel biologics to treat inflammatory disease, to the latest development in 3D medical imaging, the companies on show are among the latest crop of University and Public Institute spin-outs to have emerged in 2009/10.